Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Gavi Summit Raises US $2.4 Billion More For COVAX Global Vaccine Facility & 54 Million More COVID Vaccine Doses 02/06/2021 Raisa Santos The WHO-sponsored COVAX facility raised another US $2.4 billion on Wednesday from donors to fund more COVID vaccines for low- and middle-income countries – exceeding their total funding target and bringing the total pledged to the COVAX AMC to US $9.6 billion, following a GAVI COVAX AMC Summit “One World Protected” virtual event. But the […] Continue reading -> Big Pharma Commits to 5-Point Plan to Increase COVID-19 Vaccine Equity 19/05/2021 Kerry Cullinan Major global vaccine manufacturers and biotech companies have committed to a five-point plan to “advance COVID-19 vaccine equity”, focusing on “responsible dose-sharing” and “maximizing production”. They pointed out that, within a few months, vaccine doses had gone from “zero to 2.2 billion” and were predicted to reach 11 billion doses by the end of 2021 […] Continue reading -> Massive Moderna Investment Will Increase COVID-19 Vaccine Supply to 3 Billion In 2022 30/04/2021 Raisa Santos Moderna has announced new investments from Europe and the US to increase global vaccine supply, expecting to increase 2022 capacity to up to 3 billion doses of its COVID-19 vaccine. The announcement was followed by the World Health Organization’s (WHO) decision to list the Moderna vaccine for emergency use, making it the fifth vaccine to […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> ‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Summit Raises US $2.4 Billion More For COVAX Global Vaccine Facility & 54 Million More COVID Vaccine Doses 02/06/2021 Raisa Santos The WHO-sponsored COVAX facility raised another US $2.4 billion on Wednesday from donors to fund more COVID vaccines for low- and middle-income countries – exceeding their total funding target and bringing the total pledged to the COVAX AMC to US $9.6 billion, following a GAVI COVAX AMC Summit “One World Protected” virtual event. But the […] Continue reading -> Big Pharma Commits to 5-Point Plan to Increase COVID-19 Vaccine Equity 19/05/2021 Kerry Cullinan Major global vaccine manufacturers and biotech companies have committed to a five-point plan to “advance COVID-19 vaccine equity”, focusing on “responsible dose-sharing” and “maximizing production”. They pointed out that, within a few months, vaccine doses had gone from “zero to 2.2 billion” and were predicted to reach 11 billion doses by the end of 2021 […] Continue reading -> Massive Moderna Investment Will Increase COVID-19 Vaccine Supply to 3 Billion In 2022 30/04/2021 Raisa Santos Moderna has announced new investments from Europe and the US to increase global vaccine supply, expecting to increase 2022 capacity to up to 3 billion doses of its COVID-19 vaccine. The announcement was followed by the World Health Organization’s (WHO) decision to list the Moderna vaccine for emergency use, making it the fifth vaccine to […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> ‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Big Pharma Commits to 5-Point Plan to Increase COVID-19 Vaccine Equity 19/05/2021 Kerry Cullinan Major global vaccine manufacturers and biotech companies have committed to a five-point plan to “advance COVID-19 vaccine equity”, focusing on “responsible dose-sharing” and “maximizing production”. They pointed out that, within a few months, vaccine doses had gone from “zero to 2.2 billion” and were predicted to reach 11 billion doses by the end of 2021 […] Continue reading -> Massive Moderna Investment Will Increase COVID-19 Vaccine Supply to 3 Billion In 2022 30/04/2021 Raisa Santos Moderna has announced new investments from Europe and the US to increase global vaccine supply, expecting to increase 2022 capacity to up to 3 billion doses of its COVID-19 vaccine. The announcement was followed by the World Health Organization’s (WHO) decision to list the Moderna vaccine for emergency use, making it the fifth vaccine to […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> ‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Massive Moderna Investment Will Increase COVID-19 Vaccine Supply to 3 Billion In 2022 30/04/2021 Raisa Santos Moderna has announced new investments from Europe and the US to increase global vaccine supply, expecting to increase 2022 capacity to up to 3 billion doses of its COVID-19 vaccine. The announcement was followed by the World Health Organization’s (WHO) decision to list the Moderna vaccine for emergency use, making it the fifth vaccine to […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> ‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> ‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> ‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘WHO As Fragile As It Is Indispensable’ – Report Probes Geneva Global Health Hub’s Response To COVID Crisis 12/03/2021 Geneva Solutions One year after the World Health Organization (WHO) declared the coronavirus outbreak a pandemic on 11 March 2020, a new report by the Foundation for Geneva has traced the success and the failures of the WHO and other international Geneva organisations in their response – as well as the implications for the future of multilateralism. […] Continue reading -> More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More Investments Needed To Fight Covid-19 And Further Disease Outbreaks 09/03/2021 Chandre Prince African governments, the private sector, and development partners need to invest more in health and health systems to intensify the fight against the COVID-19 pandemic and any future disease outbreaks, according to health experts speaking at the African Health Agenda International Conference (AHAIC) on Tuesday. The experts agreed that a comprehensive, multi-sectoral approach is needed […] Continue reading -> WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Offers To Play ‘Matchmaker’ For Pharma Companies to Close Vaccine Production Gaps 05/03/2021 Kerry Cullinan The World Health Organization (WHO) and its COVAX partners are hosting a summit next week with governments and pharmaceutical companies to address the bottlenecks in COVID-19 vaccine production and delivery. This follows a spectacular start in the past week for COVAX, the global vaccine delivery platform, which delivered more than 20 million doses of COVID-19 […] Continue reading -> Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Lancet: Pandemic Containment Requires Increased Vaccine Production, Affordable Pricing & Global Allocation; WHO Calls For Tech Transfer To Scale Up Manufacturing 14/02/2021 Madeleine Hoecklin The contribution COVID-19 vaccines can make to beating the pandemic will depend on the extent to which they are produced at scale, priced affordably, and deployed globally, says the first peer reviewed study on equitable access to vaccines, published in The Lancet on Friday. The Lancet article comes in the wake of a joint appeal […] Continue reading -> Posts navigation Older postsNewer posts